- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.40 Å
- Oligo State
- monomer
- Ligands
- 1 x 01: 1-[3-[2-(cyclohexylamino)-2-oxidanylidene-ethoxy]phenyl]piperidine-4-carboxylic acid
01.1: 20 residues within 4Å:- Chain A: Y.14, S.43, G.44, R.95, I.141, G.142, F.158, R.163, S.188, G.189, Y.205, S.235, A.236, Y.252, F.257, S.282, G.283
- Ligands: SO4.8, DMS.17, DMS.18
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:Y.14, A:R.95, A:A.236, A:Y.252, A:F.257, A:F.257
- Hydrogen bonds: A:G.44, A:S.188, A:S.282
- Water bridges: A:N.94
- Salt bridges: A:R.163
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- 6 x SO4: SULFATE ION(Non-functional Binders)
- 16 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.9: 6 residues within 4Å:- Chain A: T.68, D.69, S.70, S.71, A.72, P.92
Ligand excluded by PLIPDMS.10: 3 residues within 4Å:- Chain A: W.130, H.131, L.132
Ligand excluded by PLIPDMS.11: 4 residues within 4Å:- Chain A: A.134, R.174, N.175
- Ligands: DMS.13
Ligand excluded by PLIPDMS.12: 2 residues within 4Å:- Chain A: A.87, S.88
Ligand excluded by PLIPDMS.13: 5 residues within 4Å:- Chain A: L.132, V.133, A.134, N.175
- Ligands: DMS.11
Ligand excluded by PLIPDMS.14: 3 residues within 4Å:- Chain A: R.174, E.176, R.178
Ligand excluded by PLIPDMS.15: 6 residues within 4Å:- Chain A: H.232, D.253, T.256, L.258, R.276
- Ligands: SO4.4
Ligand excluded by PLIPDMS.16: 2 residues within 4Å:- Chain A: S.213, F.226
Ligand excluded by PLIPDMS.17: 6 residues within 4Å:- Chain A: R.163, Y.205, Q.210, S.235, Y.252
- Ligands: 01.1
Ligand excluded by PLIPDMS.18: 6 residues within 4Å:- Chain A: R.95, I.141, F.158, R.163, S.188
- Ligands: 01.1
Ligand excluded by PLIPDMS.19: 3 residues within 4Å:- Chain A: H.104, R.122, E.126
Ligand excluded by PLIPDMS.20: 3 residues within 4Å:- Chain A: R.16, Q.17, P.64
Ligand excluded by PLIPDMS.21: 5 residues within 4Å:- Chain A: T.161, N.162, R.163, I.186, G.207
Ligand excluded by PLIPDMS.22: 6 residues within 4Å:- Chain A: A.146, C.193, V.194, T.240, V.241
- Ligands: CL.2
Ligand excluded by PLIPDMS.23: 6 residues within 4Å:- Chain A: Q.17, S.18, L.19, S.20, Y.21, P.41
Ligand excluded by PLIPDMS.24: 5 residues within 4Å:- Chain A: K.3, R.6, H.242, Q.243, V.288
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lin, C. et al., Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction. Angew.Chem.Int.Ed.Engl. (2025)


- Release Date
- 2025-09-03
- Peptides
- Kelch-like ECH-associated protein 1: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.40 Å
- Oligo State
- monomer
- Ligands
- 1 x 01: 1-[3-[2-(cyclohexylamino)-2-oxidanylidene-ethoxy]phenyl]piperidine-4-carboxylic acid
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- 6 x SO4: SULFATE ION(Non-functional Binders)
- 16 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lin, C. et al., Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction. Angew.Chem.Int.Ed.Engl. (2025)


- Release Date
- 2025-09-03
- Peptides
- Kelch-like ECH-associated protein 1: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A